|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Materials and supplies | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Regulatory assets-current | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| In service | ||||||||||||||||||||
| Accumulated depreciation and amortization | ||||||||||||||||||||
| Total in service, net | ||||||||||||||||||||
| Construction work-in-progress | ||||||||||||||||||||
| Electric utility plant, net | ||||||||||||||||||||
| Regulatory assets-noncurrent | ||||||||||||||||||||
| Nuclear decommissioning trust | ||||||||||||||||||||
| Non-qualified benefit plan trust | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Liabilities from price risk management activities-current | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current portion of finance lease obligation | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Regulatory liabilities-noncurrent | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Deferred investment tax credits | ||||||||||||||||||||
| Unfunded status of pension and postretirement plans | ||||||||||||||||||||
| Liabilities from price risk management activities-noncurrent | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Non-qualified benefit plan liabilities | ||||||||||||||||||||
| Finance lease obligations, net of current portion | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Preferred stock, no par value, 30,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, no par value, 160,000,000 shares authorized; 115,785,254 and 115,559,079 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
| Preferred Stock, Shares Outstanding | ||||||||||||||||||||
| Preferred Stock, Shares Issued | ||||||||||||||||||||
| Preferred Stock, Shares Authorized | ||||||||||||||||||||
| Preferred Stock, No Par Value | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Common Stock, No Par Value | ||||||||||||||||||||
| Common Stock, Shares Authorized |
Loading...
